title: Sorilux (calcipotriene) foam 0.005%.
authors.affiliation: Department of Medicine, Baylor University Medical Center, USA. dra@dermcenter.us
authors.forename: William
authors.initials: W
authors.lastname: Abramovits
authors.forename: Marcial
authors.initials: M
authors.lastname: Oquendo
authors.forename: Noah
authors.initials: N
authors.lastname: Scheinfeld
authors.forename: Aditya K
authors.initials: AK
authors.lastname: Gupta
mesh_terms: D002117:Calcitriol / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D057194:Intention to Treat Analysis; D011565:Psoriasis / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D003879:Dermatologic Agents; C055085:calcipotriene; D002117:Calcitriol